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ABSTRACT  
Objective 
Surgical treatment in epilepsy is effective if the epileptogenic zone (EZ) can be correctly 
localized and characterized. Here we use simultaneous Electroencephalography-functional 
MRI (EEG-fMRI) data to derive EEG-fMRI and Electrical Source Imaging (ESI) maps. Their 
yield and their individual and combined ability to 1) localize the epileptogenic zone and 2) 
predict seizure outcome was then evaluated.   
Methods 
Fifty-three children with drug-resistant epilepsy underwent EEG-fMRI. Interictal discharges 
were mapped using both EEG-fMRI haemodynamic responses and Electrical Source Imaging 
(ESI). A single localization was derived from each individual test (EEG-fMRI global maxima 
(GM)/ESI maxima) and from the combination of both maps (EEG-fMRI/ESI spatial 
intersection). To determine the localisation accuracy and its predictive performance the 
individual and combined test localisations were compared to the presumed EZ and to the 
postsurgical outcome.  
Results 
Fifty-two/53 patients had significant maps; 47/53 for EEG-fMRI; 44/53 for ESI; 34/53 had 
both.  The epileptogenic zone was well characterised in 29 patients; 26 had an EEG-fMRI GM 
localisation which was correct in 11; 22 patients had ESI localisation which was correct in 17; 
12 patients had combined EEG-fMRI and ESI which was correct in 11.  
Seizure outcome following resection was correctly predicted by EEG-fMRI GM in 8/20 
patients, by the ESI maxima in 13/16. The combined EEG-fMRI/ESI region entirely predicted 
outcome in 9/9 patients including 3 with no lesion visible on MRI. 
Interpretation 
EEG-fMRI combined with ESI provides a simple unbiased localisation that may predict 
surgery better than each individual test including in MRI-negative patients.  
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INTRODUCTION  
Paediatric epilepsy surgery has become increasingly important due to the potential benefits 
of earlier surgery to optimise seizure and cognitive outcome 
1
. In this patient group non-
invasive techniques able to localize the epileptogenic zone (EZ) with good sensitivity and 
specificity are particularly desirable, specifically in patients without an MRI visible lesion. 
EEG-fMRI and ESI are both good candidates but definitive studies are needed to determine 
their diagnostic performance in the paediatric population.  
Previous EEG-fMRI studies in adults have shown that fMRI can map the epileptogenic zone 
using interictal 
2, 3
 and ictal  
4
 events. Compared to clinical EEG alone, EEG-fMRI has been 
shown to provide a more accurate localisation of the epileptogenic zone (EZ) in up to 2/3 of 
the cases 
5
,to have a good degree of correlation with invasive EEG findings 
6
, and to be 
predictive of good surgical outcome 
7, 8
. However, EEG-fMRI maps often show multiple 
regions of activity which, while being consistent with the idea that epilepsy is a network 
disease 
9, 10
 
6, 11, 12
, complicates interpretation where a single spatial target  is typically 
required for surgery to proceed. Previous studies have often used the statistic global 
maxima (GM) 
8, 13
, or have constrained the search area to the spike field 
5
 or to the clinically 
defined epileptic focus 
2, 3
 to obtain a localisation. Unfortunately, these approaches can 
have low sensitivity (in the case of GM) or are dependent on subjective interpretation if 
using a clinically defined focus or are based on the interictal epileptiform discharges (IED) 
field. Furthermore, in a paediatric cohort clinical EEG is often less localizing, repeat surgery 
relatively common and therefore the use of IED fields maybe problematic. Recently EEG-
fMRI was shown to be feasible in children from 6-18 years old without sedation and possibly 
have a higher yield compared with adults in a selected population
14
 . Additionally, new 
methodological developments (topographic voltage correlation analysis)
15
 allow EEG-fMRI 
maps to be obtained without IEDs.  
ESI has been shown to localize the EZ with high sensitivity and specificity in a mixed group of 
adults and children using high density (>32 channel) EEG  
16
 and shown promise in a 
paediatric cohort 
17
.  ESI can have limitations in cases of deep sources 
18
, previous surgery 
19
 
or where IEDs are not typical discrete events and it has a limited spatial accuracy. Studies 
have investigated the spatial consistency of EEG-fMRI and ESI maps 
20, 21
 and their 
localisation performance 
22
 but they have not been combined to improve their potential 
predictive value.  
Here, high-density EEG-fMRI data was used to derive ESI and EEG-fMRI maps. We aimed to: 
a) quantify the yield; b) determine the localizing value; and c) asses the predictive value of 
EEG-fMRI and ESI individually and as combined test in the largest paediatric focal epilepsy 
population studied to date with either method. 
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METHODS 
Subjects 
Fifty-three children with drug-resistant epilepsy underwent simultaneous EEG-fMRI. At the 
point of recruitment, the children were undergoing evaluation for resective epilepsy surgery 
at Great Ormond Street Hospital for Children (London, UK). The patients were recruited 
prospectively between November 2011 and May 2015; inclusion criteria for the study were 
the presence of frequent interictal discharges and the capacity to undergo an unsedated 
MRI.  
The clinical data of the 53 patients are summarized in supplementary Table 1. Thirty 
patients had a structural lesion on MRI (56%) and twenty-three (44%) were lesion negative.  
a) Patient group for yield assessment  
All 53 patients were included in the calculation of test yield. 
b) Patient group for localisation value assessment  
All patients underwent videotelemetry-EEG to document seizures and structural MRI for 
pre-surgical assessment. In 29/53 patients the EZ was considered well-localised based on 
the following criteria: 1) MRI lesion concordant with the electro-clinical data (15 patients) or 
2) good outcome following surgery (14 patients; 12 lesional/2 non-lesional). Patients with a 
poor outcome or without an MRI lesion (unless they had a good surgical outcome) were 
excluded from this group because their EZ was not well localised. The volume of the EZ was 
estimated and these values are included in supplementary Table 1. 
c) Patient group for prediction of surgical outcome assessment 
All 20 patients within the study who underwent resective surgery were included.   Five out 
of 20 had normal MRI.  Surgical outcome for each patient was classified according to the 
modified ILAE classification system 
23
 before being further divided into good or poor 
outcome based on the surgical goal being met. Good outcomes were therefore considered 
to be ILAE class 1 and 2. In 3 patients with large lesions (involving more than one lobe) a 
partial resection of the lesion was chosen in order to spare eloquent cortex. In these 
patients if a significant seizure reduction of >50% was achieved (ILAE class 4) the outcome 
was considered to be a favourable as this was the a priori surgical aim. For all other 
categories outcome was considered to be poor. The relative brain volume that was resected 
was estimated and these values are included in supplementary Table 1. 
EEG-fMRI acquisition 
Full scanning protocol details are described in our previous work 
14
. Patients were prepared 
with a 64-electrodes MRI compatible EEG cap (Easy cap, Brain Products, Munich, Germany). 
All patients underwent between 2 to 4 EEG-fMRI sessions lasting 10 minutes each (300 
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volumes TR 2.16s) and a T1-weighted whole-brain structural image. In order to keep 
consistency across subjects only the first two sessions (20 minutes) of EEG-fMRI were used 
in the analysis with the added benefit of reduced subject movement without affecting BOLD 
results
14
.  In 2 patients in whom seizures with movement occurred during the first 2 sessions 
the subsequent sessions free of seizures were analysed.  
Pre-processing of EEG and identification/classification of interictal epileptiform discharges 
(IED) on EEG traces were carried out as described previously in Centeno et al. 
14
. In 
summary, IED for each subject were classified as a separate IED type according to the 
topographical distribution of the activity
13
. 
EEG-fMRI analysis 
IED-correlation analysis 
A mass univariate fMRI analysis was performed using SPM8 version r5232 
(http://www.spm.fil.ion.ucl.ac.uk) running in matlab (Mathworks, Natick, USA). 
Pre-processing consisted of image realignment (SPM8) followed by the removal of  non-
physiological signal changes using FIACH 
24
. Slice time correction and smoothing with an 
8mm kernel was subsequently applied (SPM8).  
A general linear model was generated for each subject where for each IED type, IED onset 
(and duration in the case of IED runs) was convolved with the canonical HRF and its time and 
dispersion derivatives. Motion realignment parameters and FIACH physiological noise 
regressors 
14, 24
 were entered as effects of no interest. Brain regions with signal changes 
associated with each IED type were tested with an F-test across the three IED regressors 
(HRF and the two derivatives) to account for variability in the haemodynamic response 
shape 
25, 26
.  A more detailed explanation of the model used can be found in Centeno et al. 
14
.  
Topographic IED voltage map correlation 
In those patients in whom IED were not captured during the EEG-fMRI sessions, a regression 
analysis of the typical IED topographic voltage maps was applied to the EEG-fMRI data 
following the procedure described by Grouiller et al 
15
. In brief, a patient’s IED topography 
derived from their clinical EEG is spatially correlated with the topography of the EEG 
obtained inside the scanner at each time point. The fMRI signal changes associated with an 
increased correlation to the IED topography are obtained, which can reflect the generators 
of focal epileptic activity 
27, 28
.  
Changes in Blood Oxygenation Level Dependant (BOLD) fMRI signal were considered 
significant at an individual level above a threshold of p<0.001 (uncorrected) and a cluster 
size voxel with a minimum of 5 contiguous voxels
14
. This threshold is arbitrary but was 
chosen apriori to strike an appropriate balance between sensitivity and specificity based on 
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the range of design efficiency that is encountered between patients.  This threshold was 
applied to both IED-related and topographic correlation analysis maps. 
Electrical source imaging 
Only patients with IEDs captured during the EEG-fMRI sessions (using a 64 electrode cap) 
had electrical source imaging (ESI). We calculated the ESI of each IED type identified on the 
EEG using Cartool software (https://sites.google.com/site/fbmlab/cartool) and followed the 
procedure described in Vulliemoz et al. 
29
.  
Localisation derived from EEG-fMRI and ESI individually and combined 
A single localisation was derived from each EEG-fMRI and ESI map used individually and 
then subsequently a combined localisation was derived (Fig 1). 
Individual test localisation 
The single localisation obtained from EEG-fMRI maps was the cluster containing the 
statistical global maximum. The single localisation from the ESI maps was the ESI maxima 
solution point for the map corresponding to the 50% rising phase of the IED. 
Combined EEG-fMRI/ESI localisation 
To obtain a single localisation from the combination of EEG-fMRI and ESI, both maps were 
coregistered and overlaid on the subject’s structural T1-wighted image. Combined EEG-
fMRI/ESI localisation was extracted in those cases in whom ESI maxima and an EEG-fMRI 
cluster were localised to the same sublobar region. Sublobar regions were defined as 
follows
30
 : frontal polar, dorsal lateral frontal, mesial frontal, lateral parietal, mesial parietal, 
lateral occipital, mesial occipital, lateral temporal, temporal polar, and mesial temporal.  The 
location derived from the combined EEG-fMRI and ESI maps was defined as the region that 
comprised both the ESI maxima and the nearest EEG-fMRI cluster within the same sublobe. 
Additionally, the Euclidian distance between the ESI maxima and EEG-fMRI cluster located in 
the same sublobe was calculated for the combined EEG-fMRI/ESI cases.  
Assessment of the value of the EEG-fMRI and ESI   
a)  Test yield  
To determine the ability of the test to provide a localisation result the ‘test yield’ was 
calculated and is given by the number of patients with a test localisation result/total 
number that received the test.  
b) Localisation accuracy  
Here, we aimed to address the question ‘given a test localisation result, what is the 
probability that it is correct?’. To do this, the patient group with a well localised EZ (n=29 
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see above) was used (Fig 2). When the test resulted in a localisation and it fell within the EZ 
it was classed as a true positive (a correct localisation); otherwise if the test resulted in a 
localisation and it did not fall within the EZ it was considered a false positive (an incorrect 
localisation). This was repeated for the individual localisation results from ESI and EEG-fMRI 
and for the combined localisation. Note that where the test does not provide a localisation, 
the test cannot be categorised as providing true or false, positive or negative localisation 
information (the absence of evidence cannot be taken as evidence of absence). 
c) Surgery outcome prediction  
Thirdly we aimed to assess the ability of EEG-fMRI and ESI localisation to predict seizure 
outcome (Fig 2). In patients who underwent surgery, we defined a true positive as being 
when the localisation provided by the test was resected with a good outcome; false positive 
as when the localisation provided by the test was resected followed by a poor outcome. 
True and false negatives were defined as the localisation provided by the test not being 
resected and the outcome being poor and good respectively
8
.  True positives and true 
negatives were considered correct predictions (prediction successes), otherwise the 
prediction was incorrect (prediction failures).  
Statistical analysis and confidence estimates  
Binomial calculations are often used to quantify uncertainty in diagnostic test sensitivities 
using confidence intervals. However, these intervals are inaccurate if percentages approach 
100%. We therefore adopted a Bayesian approach to estimating the sensitivity and the 
associated  uncertainty. The prior information we incorporate is in the form of a Beta 
distribution which is the typical prior for proportions 
31
. The Beta distribution has two 
parameters:  α and β which both have a meaningful clinical interpretation. For EZ 
localisation, the parameter α is simply the number of times a given test correctly localised 
the EZ. Whereas the β parameter is the number of times the test incorrectly localised the 
EZ. For surgical prediction α is the number of successful predictions (true positives plus true 
negatives) whereas β is the number of failures (false positives plus false negatives).  
The values for α and β for the prior distribution can incorporate information from previous 
studies. When none is available the starting assumption is that α and β are equally likely and 
so α=β=1 (in this special case the prior is a uniform distribution also called a flat prior).  For 
EEG-fMRI-GM we incorporated information from two studies 
8, 13
.  The resulting prior for 
EEG-FMRI-GM sensitivity() was ~14,10.  For ESI we used the study by Brodbeck et 
al
16
. The resulting prior for ESI is ~45,9.  In the absence of data for the combined 
method the prior remained uninformative (~1,1).This prior remained the same for 
the localisation sensitivity and the prediction of surgical outcome. These priors were then 
used together with our data to describe the posterior distribution of sensitivity in the 
population. The uncertainty was then simply characterised using a 95% credible interval 
calculated using the 0.975 and 0.025 quantiles of the posterior distribution.  
Page 8 of 33
John Wiley & Sons
Annals of Neurology
This article is protected by copyright. All rights reserved.
  
The chance level of localisation was based on the estimated EZ volume or resection volume 
(see supplementary Table 1). The distribution of this variable was unknown a priori. In order 
to calculate the mean chance level of localisation and associated measures of uncertainty 
we therefore used a bootstrap procedure. This was implemented in the boot package of the 
R Programming language
32, 33
. The number of bootstrap replicates was 5000. Credible 
intervals were calculated using the 0.975 and 0.025 quantiles of the resulting distribution of 
the mean. The sensitivity of a given test lies within the credible interval with 95% probability 
and is therefore considered here to be significantly improved (relative to chance levels or 
other tests) when the 95% intervals did not overlap.  
RESULTS 
Forty-four out of 53 patients (83%) had IED during EEG-fMRI sessions. The number of IED 
types per patient ranged from 1 to 4 (mean 1.6). Twenty-four patients (54%) had 1 IED type; 
fourteen patients (31%) had 2 types of IED, five patients (11%) had 3 types of IED and one 
patient (2%) had 4 types of IED (supplementary Table 2). The results are summarised in 
Table 1. 
a) Test Yield 
In summary, 52/53 patients (98%) had a significant result for at least one of the tests. 
Forty-seven/53 patients had significant clusters of activity on the EEG-fMRI maps (88% test 
yield). Thirty-nine of the EEG-fMRI maps were IED-related and eight were topographic-
voltage-correlation maps (8/9 patients without IEDs). The EEG-fMRI maps contained more 
than one cluster in 46 out of 47 patients.  
ESI was obtained in 39/53 patients (73% test yield). In fourteen patients ESI could not be 
obtained due to the following reasons: no IED (nine patients); IED rhythmic irregular bursts 
(one patient), EEG artefact (one patient), structural MRI pre-processing problems (three 
patients). 
The combined ESI/EEG-fMRI gave a single localisation in 23/53 patients (43% test yield). In 
11/23 patients, the EEG-fMRI cluster that was concordant with ESI was the global maxima. 
The mean distance between EEG-fMRI and ESI maxima was 14.6 mm ranging from 5 to 30 
mm in the combined EEG-fMRI/ESI. A summary of test yield for MRI negative and lesional 
patients is shown in Figure 3. Details of individual subject’s localisation derived from EEG-
fMRI/ESI used individually and combined can be found in supplementary Table2. 
 
b) Localisation accuracy  
Twenty-six out of the 29 patients with a well characterized EZ  had significant BOLD changes 
on EEG-fMRI maps; 11/26 correctly localised the EZ with the GM.  Twenty-two patients out 
of the 29 had an ESI map; in 17/22 the maxima correctly localised the EZ. Twelve out of the 
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29 had a combined localisation from EEG-fMRI and ESI maps; 11/12 correctly localised the 
EZ (Table 1). The localisation performance of all tests was above chance levels. Both ESI and 
the combined test were better at localising than the EEG-fMRI GM method based on the 
criteria of non-overlapping 95% intervals (see table 1).  
c) Surgical prediction accuracy 
Twenty patients underwent surgery and had post-operative outcome (mean 29 months, 
range 10 to 57 months). Eleven patients (55%) were seizure free. Nine patients continued 
having seizures after surgery and were classified as ILAE class 2 (1 patient), class 4 (3 
patients) and class 5 (5 patients) (see supplementary Table 1). Two of the patients 
underwent a partial resection of a large lesion with the aim of significantly reducing the 
seizure burden but not necessarily seizure freedom. These patients (#28 and #39) had an 
outcome ILAE 4, with a reduction >of 50% and so were additionally considered as having a 
good outcome based on the different aim of the surgery. Therefore, the total number of 
patients with good outcome was 14/20. Five patients in the surgical group were MRI 
negative (#2,#7,#25,#44,#50). Four of these had both EEG-fMRI and ESI maps with three of 
them having a combined EEG-fMRI/ESI localisation (#25,#44,#50). 
Outcome was correctly predicted in 8/20 patients by the EEG-fMRI GM, in 13/16 by ESI and 
in 9/9 by combined EEG-fMRI and ESI. The predictive performance of all tests was above 
chance level, and both ESI and the combined test were better at localising than the EEG-
fMRI GM methods based on the criteria of non-overlapping 95% intervals (see table 1) 
DISCUSSION 
In this study, we retrospectively evaluated the potential localising and predictive value of 
EEG-fMRI and ESI individually and when used as a combined test in the largest paediatric 
focal epilepsy population studied to date with either method. 
The yield of EEG-fMRI alone was 89%, ESI alone 73% and combined EEG-fMRI/ESI 43%. Low 
yield has been highlighted as a limiting factor for the clinical use of EEG-fMRI. Studies report 
significant findings in 27% to 76% of the cases 
2, 5, 13
. The improvement in the yield in our 
study may be explained by the population of paediatric patients studied whom typically 
have frequent IED and the use of topographic correlation analysis (which allowed a 
localisation to be achieved in the cases without IEDs). 
All tests were more accurate than chance levels of correct localisation (Table 1). Both 
combined ESI/EEG-fMRI (92%) and ESI (82%) were more accurate than the EEG-fMRI GM 
localisation (50%). The results for surgical outcome prediction were consistent with the 
localisation results. All tests were significantly more predictive than chance levels. Both 
combined ESI/EEG-fMRI (91%) and ESI (83%) were more accurate than the EEG-fMRI GM 
localisation (50%). Importantly this surgical group of 20 included 5 patients without an MRI 
lesion. ESI obtained a localisation in 4/5 and in all patients it was predictive of outcome. 
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Combined EEG-fMRI/ESI obtained a localisation in 3/5 and in all patients it was predictive of 
outcome. 
Comparison with previous studies 
Previous studies have shown the potential of EEG-fMRI maps to localize and contribute to 
the EZ characterization
2, 5, 8, 13
. However, the localisation accuracy of EEG-fMRI remains 
poorly characterized in the literature. EEG-fMRI maps often show a multifocal pattern of 
significant responses and this has led to different ways of extracting a single localisation 
from an EEG-fMRI map.  The statistic global maximum has often been used as the marker of 
the cluster likely to represent the EZ 
5, 8
. Although the GM is an unbiased and easy method 
to extract a single location from a multifocal EEG-fMRI map it suffers from poor sensitivity 
because it is often located in regions remote from EZ. In a recent study 
8
 the EEG-fMRI GM 
was shown to have a sensitivity of 45% to localize the EZ which is in line with our findings.  
The meaning and clinical significance of the often multi-focal EEG-fMRI maps of interictal 
epileptiform activity remains unclear, a fact closely related to the problem of defining the 
test’s localisation result. In this study, we proposed an alternative and unbiased method to 
extract a single location from EEG-fMRI data by incorporating the IED information through 
ESI maps and assessing the concordance between them. This method relies exclusively on 
imaging information, avoiding the interpretation bias of viewing EEG-fMRI and ESI maps in 
light of clinical information.  However, despite being very accurate, the yield of combined 
ESI and EEG-fMRI was modest (23/53) compare to EEG-fMRI (47/53) in our patient group. 
Given the high yield but low accuracy of the EEG-fMRI GM to define the EZ, the clinical 
utility of EEG-fMRI could potentially be dramatically improved by epileptic network 
characterisation methods that can define the EZ and regions of propagation directly from 
EEG-fMRI data
29
.  Studies focused on comparing these results with the epileptiform activity 
measured invasively, including with simultaneously acquired fMRI 
34, 35
, may help resolve 
this issue. 
EEG-fMRI clusters of activity and ESI maps have been shown to have both a good spatial 
consistency with the icEEG findings but they do not completely overlap 
20
.  Bagshaw et al 
36
 
reported a mean distance of ~60 mm between the ESI  and EEG-fMRI activity clusters 
obtained in separate sessions. In our data we found an average distance of 14 mm with a 
range (5 to 30) in the cases where a concordant localisation was found with EEG-fMRI and 
ESI. These distances and the concordance between ESI and EEG-fMRI GM are consistent 
with a previous study in adults 
29
. This difference could suggest that each technique is more 
sensitive to different regions involved in the IED and may contribute to a better 
characterization of EZ than each map alone. However, EEG source localisation is typically 
considered to have a spatial accuracy of order ~1cm and there are likely to be differences in 
the location of the maxima of regional electrical and hemodynamic responses the latter 
being sensitive to the local vascular architecture. These methodological considerations 
could easily account for the average difference in localisation of 14mm found here. There 
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are a number of methodological choices that could influence the accuracy of the ESI results. 
A greater EEG density (above the 64 channels used here) may improve the spatial accuracy 
of ESI 
37, 38
. We used a Spherical Head Model with Anatomical Constraints (SMAC) based on 
a 3-shell spherical realistic head model and the patient's individual MRI spherical head 
model, this is an active area of research and more advanced and specific models may also 
improve accuracy 
38
 . These methodological choices were motivated by our desire to make a 
comparison to the largest study of the application of ESI to presurgical epilepsy evaluation in 
the literature 
37
 and so we therefore followed the same approach. 
ESI was shown to accurately map the generators of IED from data obtained during an EEG-
fMRI recording in our paediatric population, providing useful predictive information for the 
presurgical assessment. The sensitivity of ESI alone to localise the EZ was 82% which 
replicates the results in  a previous study, which examined a mixed cohort of adults and 
children using EEG data from outside the scanner
16
. ESI is therefore a technique that can 
provide a relatively low cost minimally invasive test with high accuracy in the context of 
evaluation for paediatric epilepsy surgery. However, its accuracy may be more limited in 
some cases such as those with deep sources, or in patients with brain and skull 
abnormalities. In our sample, there were 6 cases in whom ESI was inconsistent with the MRI 
lesion. Four of them were patients with deep lesions and one patient had undergone 
previous surgery.  
To determine test sensitivity and their reliability we used a Bayesian approach. This allowed 
the incorporation of prior information (where available) to increase the confidence in our 
results. For ESI and EEG-fMRI-GM the priors on the sensitivity were very consistent with the 
data from the current study and therefore their incorporation had little effect on the 
sensitivity but reduced the credible interval (crucially allowing for more accurate population 
level inference). For the combined EEG-fMRI/ESI the uninformative prior reduces the 
sensitivity estimate (reflecting our uncertainty in this novel methodology due to low 
numbers). Using this approach, future studies can readily update these numbers to further 
refine these sensitivity estimates by using our posterior distributions as priors in their work.        
Clinical value 
The aim of presurgical evaluation is to identify a clear hypothesis for the EZ that can be 
confirmed by intracranial recording or allows for surgery to be offered with an appropriate 
understanding of risk-benefit. In patients that have an MRI lesion consistent with electro-
clinical information this is often achieved. However, for patients without an MRI lesion it 
becomes difficult to formulate a spatially constrained hypothesis. PET and SPECT can be 
used to formulate a spatial hypothesis 
39
, however the spatial accuracy of these techniques 
is poor. In this study, we have shown that a combined EEG-fMRI & ESI result from a single 
data set is highly localizing and predictive of surgical outcome with or without an MRI lesion.  
Furthermore, the localisation provided by these tests (typically at the sublobar level) is more 
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spatially accurate than most of the current non-invasive presurgical test (EEG, PET & SPECT) 
which are used to localize the EZ in patients with no MRI lesion. 
Limitations 
This study is limited by the numbers in the subgroup of patients in whom the validation of 
the localisation results could be carried out (29/53). This represents a potential (but 
unavoidable) bias, because the patients in whom an EZ is well characterised may not fully 
represent the sample. We included a group of 23 MR negative patients that have a poorer 
likelihood of having a well-defined EZ, and therefore surgical outcome data. This choice was 
necessitated by the need for an assessment of the localisation tests accuracy in this group. A 
combined EEG-fMRI/ESI localisation was found in 12/23 MRI negative patients and outcome 
was predicted in all 3 whom had surgery. Our results therefore strongly motivate a larger 
study of combined EEG-fMRI and ESI in MRI negative patients with validation based on 
intracranial EEG or surgery.   
Patients with a well-defined cortical MRI abnormality concordant with electro-clinical 
information are unlikely to benefit from EEG-fMRI given its cost. In these cases, based on 
our data, ESI represents an additional relatively low-cost test with a good sensitivity in 
children with frequent IEDs. However, patients without an MRI visible abnormality, a deep 
lying or extensive MRI abnormality, and/or prior surgery are likely to benefit from combined 
EEG-fMRI and ESI. 
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FIGURE LEGENDS 
 
Figure 1: Localisation extraction procedure  
From left to right; EEG-fMRI data is used to obtain a map for EEG-fMRI and ESI. For each of 
these individual maps a single localisation is selected: for the EEG-fMRI the global maxima is 
selected and for the ESI the maxima in the map from the 50% rising phase of the IED is 
selected. For the combined test the localisation is derived from the spatial conjunction of 
both maps. Where the maps are concordant the localisation is the region encompassing the 
ESI max and the closest significant EEG-fMRI cluster located in same sublobe. When the 
maps are discordant cases no combined localisation is extracted.  
 
Figure 2: Validation of individual and combined EEG-fMRI and ESI maps 
The localisations derived from the single and combined test were validated by:  
1) Calculating localisation accuracy in those patients with a well characterized EZ. For 
each localisation method its accuracy was classified as a true positive (TP) if it was 
located in the presumed EZ  (top row) or False positive (FP) if it was not;  
2) Calculating the prediction accuracy for seizure outcome in all patients who 
underwent surgery (bottom row). Here a true positive (TP) was a localisation within 
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the resection margins and good outcome; a false negative (FN) was a localisation 
within the resection margins and poor outcome; true (TN) and false negatives (FN) 
were a localisation that was not within the resection margins and a poor or good 
outcome respectively. 
 
Figure 3: Summary flowchart 
The number of significant results for each of the test individually and in combination is 
summarised in for the MRI negative and MRI lesion patients respectively. The diagram 
shows the number patients with a combined EEG-fMRI/ESI result that were validated by 
surgical outcome for MRI lesion and MRI negative patients.  
 
Table Legends 
Table 1: Yield, localisation accuracy and prediction accuracy   
Test yield is calculated as the number of subjects in whom a significant map was obtained.  
Localisation accuracy was calculated in those patients with well localized epileptogenic zone 
(EZ), and surgical prediction in those patients who underwent surgical resection. n is the 
number of subjects where the test provided a result. The current study summary row gives 
the number of true positives (TP), false positives (FP), true negatives (TN) and false 
negatives (FN) . The test sensitivity is, given a result, the likelihood it was correct; α and β 
are the hyperparameters of the beta distribution. Prior hyperparameters are based on the 
results of previous studies where available or are set to both equal 1 where there is no prior 
information.   
  
Supplementary Table1: Clinical data. 
Presumed epileptogenic zone (EZ) is the region where the EZ was located after non-invasive 
test.  In those patients with well characterized EZ (presence of MRI lesion or good surgical 
outcome) the relative volume of EZ was estimated by the following process. When the 
resected cavity or MRI lesion was defined as being at a hemisphere level a volume of 0.5 
was assigned, lobar level lesions or resections were assigned a relative brain volume of 0.1 
for occipital, temporal and parietal lobes and 0.2 for the frontal lobe. For sublobar lesions or 
resections the volume was estimated by expert visual assignment of the AAL atlas regions 
involved (M.C.). The relative volume was then calculated as a sum of AAL regions relative 
volume. One patient had a hypothalamic haematoma and therefore a relative volume of 
0.03 was used. Note that this approach was used to provide a maximum bound on the EZ 
volume and therefore a conservative statistical assessment of localisation probabilities.                                    
Abbreviations: m=male f=female L=left R=right TL=temporal lobe No=no MRI lesion 
DNET=Dysembryoplastic neuro epithelial tumour FCD=focal cortical dysplasia.  AED= 
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antiepileptic drugs; VPA=valproate TPM=topiramate CBZ=carbamazepine LMT=Lamotrigine 
CBZ =Clobazam OXC=Oxcarbazepine LVT=Levetiracetam PHE=Phenytoin RUF=Rufinamide 
PPN=Perampanel VGB=Vigabatrin AZAT=Azathioprine                                                                                                         
Surgery outcome for the 20 patients who underwent surgery is classified using the ILAE 
classification. 
 
Supplementary Table 2: EEG-fMRI and ESI results: Availability and localisation of EEG-fMRI 
and ESI results for each subject.  
Significant results for EEG-fMRI and ESI maps are indicated with a . No available results for 
the test are indicated with X. The concordance column shows whether EEG-fMRI and ESI 
maps where concordant (=C) or discordant (=D) for those cases that have both maps. The 
localisation of EZ column contains the cases in whom the localisation of each single test and 
combine test correctly identifies the ER (TP=true positive) or not (FP=false positive). The 
surgery prediction column displays the results for the localisation of individual and 
combined EEG-fMRI and ESI correctly predict surgery outcome (TP=true 
positive=localisation included in resection+good outcome); (FP=false positive=localisation 
resected and poor outcome); (TN-true negative=localisation not resected+poor outcome); 
(FN=false negative=localisation not resected+good outcome). 
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Figure 1: Localisation extraction procedure  
From left to right; EEG-fMRI data is used to obtain a map for EEG-fMRI and ESI. For each of these individual 
maps a single localisation is selected: for the EEG-fMRI the global maxima is selected and for the ESI the 
maxima in the map from the 50% rising phase of the IED is selected. For the combined test the localisation 
is derived from the spatial conjunction of both maps. Where the maps are concordant the localisation is the 
region encompassing the ESI max and the closest significant EEG-fMRI cluster located in same sublobe. 
When the maps are discordant cases no combined localisation is extracted.  
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Figure 2: Validation of individual and combined EEG-fMRI and ESI maps  
The localisations derived from the single and combined test were validated by:  
1) Calculating localisation accuracy in those patients with a well characterized EZ. For each localisation 
method its accuracy was classified as a true positive (TP) if it was located in the presumed EZ  (top row) or 
False positive (FP) if it was not;  
2) Calculating the prediction accuracy for seizure outcome in all patients who underwent surgery (bottom 
row). Here a true positive (TP) was a localisation within the resection margins and good outcome; a false 
negative (FN) was a localisation within the resection margins and poor outcome; true (TN) and false 
negatives (FN) were a localisation that was not within the resection margins and a poor or good outcome 
respectively.  
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Figure 3: Summary flowchart  
The number of significant results for each of the test individually and in combination is summarised in for 
the MRI negative and MRI lesion patients respectively. The diagram shows the number patients with a 
combined EEG-fMRI/ESI result that were validated by surgical outcome for MRI lesion and MRI negative 
patients.  
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ID AGE GENDER MRI LESION PRESUMED EZ RELATIVE 
VOLUME 
EZ 
AED SURGERY TYPE OF 
SURGERY 
OUTCOME 
(ILAE) 
#1 8 f Tuberosclerosis. L 
temporal prominent 
tuber 
L temporo-parietal 0.015 ZNS N   
#2 14 f No L Frontal 0.018 LAC, 
LVT 
Y Frontal tailored 
resection 
5 
#3 11 m Hypothalamic 
hamartoma 
L temporal 0.03 LVT N   
#4 15 m No L posterior 
quadrant 
 CBZ N   
#5 11 f No R F-T Junction  LAC, 
GBP, 
CLBZ 
N   
#6 17 m R parietal FCD R parietal 0.034 LVT, 
CLBZ, 
VPA 
N   
#7 15 m No R Frontal 
medial/lateral 
0.018 CBZ Y Frontal tailored 
resection 
1 
#8 17 f L Temporal FCD L temporal 
posterior 
0.091 LVT Y L temporal 
lobectomy 
1 
#9 11 f Perinatal L 
hemisphere cortical 
atrophy 
L hemisphere 
possible central 
region 
0.5 OXC N   
#10 14 f R temporal FCD 2B R temporal 0.075 LVT, 
TPM 
Y R Temporal 
lobectomy 
1 
#11 11 f No R Fronto-temporal  CBZ, 
LMT 
N   
#12 11 m No R F-T  CBM, 
TPM 
N   
#13 10 f R frontal pole FCD R fronto-polar 0.009 OXC Y Frontal tailored 
resection 
1 
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#14 12 m Skull malformation/ 
R hemispheric 
cortical atrophy 
R hemisphere 
possibly multifocal 
0.5 VPA N   
#15 17 f No R frontal  LTG 
LEV 
N   
#16 16 f No L frontal  VPA 
CBZ 
N   
#17 11 f No L frontal (Medial 
frontal 
cingulum/frontal 
operculum) 
 OXC, 
CLBZ 
VGB 
N   
#18 17 f L posterior temporal 
astrocytoma. 
Previous resection 
L temporal lobe 0.013 TPM 
OXC 
N   
#19 14 m Autoinmune L 
hemisphere  cortical 
atrophy 
L hemisphere. 
Medila temporal 
semiology 
0.5 AZIA, 
VPA 
MDZ 
Y Hemispherectomy 4 
#20 16 f L insular FCD L insula-deep 0.004 TPM 
CBZ 
N   
#21 18 m R precuneus FCD 
2A 
R precuneus 0.013 LAC 
LMT 
PGB 
TPM 
Y Parietal resection 5 
#22 11 m No R frontal  CBZ N   
#23 11 m No R frontal  LVT 
VPA 
N   
#24 16 f L T-P-O 
polymicrogyria 
/Unspecific cortical 
atrophy 
Deep L 
hemisphere lesion 
0.3 LVT 
CLNZ 
N   
#25 15 m No T-P-O/ temporal 
medial 
0.091 LMT 
ZNS 
Y Temporal 
resection 
5 
#26 15 m No L temporal  OXC 
LEV 
N   
#27 17 f No Frontal  OXC N   
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#28 8 f L middle cerebral 
artery stroke 
L frontal 0.2 VPA 
LVT 
ETHx 
Y Anterior quadrant 
disconnection 
4 
#29 17 m L post-central FCD Parietal 0.013 LVT Y  4 
#30 16 f L perisylvian 
polymicogyria 
L perysilvian 0.071 PPN Y Partial frontal 
resection 
4 
#31 16 m No R frontal  CBZ 
LVT 
N   
#32 11 m L choroid plexus 
papilloma. L 
posterior quadrant 
atrophy secondary 
to radiotherapy 
L posterior 
quadrant 
0.2 VPA 
CBZ 
PPN 
N   
#33 13 m L middle frontal 
gyrus FCD 
R frontal 0.017 OXC 
CLBZ 
 
Y Partial frontal 
resection 
1 
#34 10 f No L frontal  LVT 
CBZ 
N   
#35 10 m No R T-P-O  OXC N   
#36 14 m L middle cerebral 
artery stroke 
L occipital 0.5 OXC 
GBP 
Y Hemispherotomy 1 
#37 17 m No Unknown  LVT 
OXC 
CLBZ 
N   
#38 17 m L occipital atrophy. 
Iquemic perinatal 
insult 
R occipital 0.1 OXC 
LMT 
LVT 
N   
#39 13 m L T-P-O cortical 
atrophy perinatal 
L occipital 0.212 CBZ 
TPM 
CLBZ 
Y Posterior quadrant 
disconnection 
4 
#40 18 f R frontal FCD R frontal 0.042 LMT Y Partial frontal 
resection 
2 
#41 17 f Bilateral oribito-
frontal 
Bilateral orbito-
frontal 
0.009 LVT 
VPA 
N   
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polymicrogyria 
#42 17 m R T-P-O junction 
postusurgery 
residual FCDi 
Fronto-parietal 0.007 OXC 
TPM 
RUF 
N   
#43 15 m No Frontal medial  VPA 
LAC 
CLBZ 
N   
#44 11 f No R parietal 0.019 OXC 
PHE 
CLBZ 
Y Partial parietal 
resection 
5 
#45 17 m No Frontal lobe  LVT 
LAC 
N   
#46 18 m R inferior 
parietal  residual 
postsurgical DNET 
R parietal 0.018 LAC 
LMT 
N   
#47 11 f R parietal FCD R parietal 0.021 OXC 
CLBZ 
VPA 
Y Partial parietal 
resection 
1 
#48 13 f R amygdala DNET R medial TL 0.04 TPM Y Anterior temporal 
lobe resection 
1 
#49 12 m Bilateral perisylvian 
polymicrogyria 
R fronto-parietal 
junction 
0.048 VPA 
LVT 
CBZ 
CBZ 
N   
#50 17 f No L frontal midline 0.018 VPA Y Partial frontal lobe 
resection 
1 
#51 13 f L inferior frontal 
FCD 
L frontal 0.025 VPA N   
#52 15 f R posterior cingulate 
DNET 
R medial parietal 0.002 LVT 
LMT 
Y R posterior 
cingulate resection 
1 
#53 7 m No L frontal  LVT 
OXC 
CLBZ 
N   
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Chance Level EEG-FMRI_GM ESI 
Combined 
Method 
Y
ie
ld
 
n
=
5
3
  
Test Yield 
  
47/53 (89%) 39/53 (73%) 23/53 (43%) 
Lo
ca
li
sa
ti
o
n
 
n
=
2
9
 
n 29 26 22 12 
Current study-summary  TP=11, FP=15 TP=17, FP=5 TP=11, FP=1 
Current study - α=11, b=15 α=17, β=5 α=11, β=1 
Prior Hyperparameters - α=14, β=10 α=45, β=9 α=1, β=1 
Posterior Distribution - α=25, β=25 α=62, β=14 α=12, β=1 
Sensitivity  11% 25/50 (50%) 62/76 (82%) 12/13 (92%) 
95% Credible Interval 6%-17% 36 - 64% 72% - 89% 64% - 98% 
P
re
d
ic
ti
o
n
 
n
=
2
0
 
n 20 20 16 9 
Current study-summary  TP=3, TN=5, 
FP=1, FN=11 
TP=10, TN=3, 
FP=1, FN=2 
TP=7, TN=2, 
FP=0, FN=0 
Current study - α=8, β=12 α=13, β=3 α=9, β=0 
Prior Hyperparameters - α=14, β=10 α=45, β=9 α=1, β=1 
Posterior Distribution - α=22, β=22 α=58, β=12 α=10, β=1 
Sensitivity  10% 22/44 (50%) 58/70 (83%) 10/11 (91%) 
95% Credible Interval 4%-17% 36 - 65% 73% - 91% 69% - 100% 
 
 
Table 1: Yield, localisation accuracy and prediction accuracy   
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